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DISCUSSION
Dr Ali F. AbuRahma (Charleston, W Va). I want to
compliment Dr Back and his group on a well-designed
study that analyzes the role of MRA in minimizing the need
for cerebral angiography in patients with inadequate ca-
rotid duplex imaging. Although there have been over a
dozen studies that have reported on this topic, this study
describes a specific protocol to be followed in these patients
prior to carotid endarterectomy, to minimize the necessity
of cerebral angiography to 6% of MRA studies and, amaz-
ingly, to only 0.2% of patients initially evaluated by carotid
duplex ultrasound for angiography.
Specific anatomic criteria and categories defining inad-
equate or undetermined carotid duplex scan were outlined.
Modern duplex ultrasound is inexpensive, fast, repeatable
with good resolution of carotid plaque morphology, and
has an excellent accuracy in most experienced medical
centers. However, it does have limitations, as shown in this
study. Therefore screening exam based on carotid duplex
ultrasound alone may be incomplete for certain surgical
patients. As noted in this study, only 3.8% of patients who
had carotid duplex ultrasound in their lab were deemed to
have inadequate duplex exam, a remarkable result for which
Dr Back and Dennis Bandyk and their group are to be
commended. I have the following questions for Dr Back.
Do you think this study is somewhat limited by its
subjectivity, since technical adequacy was judged by a single
reader, which I presume was Dr Back?
You indicated that internal carotid near-occlusion was
delineated by MRA in only 75% of patients, which seems
somewhat low to me. Can you explain this finding?
And finally, do you think that the new 3-D power
imaging will further reduce the need of MRA and carotid
angiography?
I want to thank Dr Back for sending me the manuscript
in advance, and I want to thank the society for the privilege
of discussing this paper.
Dr Martin R. Back. Certainly this is a subjective study.
It was performed in a single center, which was our veterans
hospital. I am the chief there, and review all the studies.
What we tried to establish prospectively was a protocol that
would give some usable duplex imaging guidelines for
adequacy. This protocol attempts to make the study more
objective, but I think comfort level with duplex imaging
needed to proceed to endarterectomy is still a moving
target, and policies differ between centers.
Your second comment regards near-occlusions. The
percentage adequately imaged seems low. There are two
issues. First of all, there is resolving patency of the ICA. The
second question is operability. Even if you have a patent
ICA and you have a near-occlusion, you may not be com-
pletely sure, based upon the duplex, of the status of the
more distal internal carotid artery. Because of those very
faint images on the MRA associated with very low flow
rates, you may not be completely comfortable that there is
not more disease present distally. I showed an MRA exam-
ple where we did not need to proceed to an arteriogram to
confirm operability of the lesion, but we had some cases
that required the arteriogram to really better define the
distal ICA anatomy.
Finally, your last comment on gadolinium enhance-
ment and use of 3-D time-of-flight techniques. Such tech-
niques may be slightly better because they eliminate some
of this flow gap phenomenon that occurs. However, vali-
dation of MRA flow gaps against duplex findings and
angiographic stenoses has allowed us to become comfort-
able with standard 2-D time-of-flight techniques that are
commercially available. There are no data to say that the
gadolinium aids operative planning, and there have been no
clinical studies comparing 2-D or 3-D time-of-flight tech-
niques and gadolinium enhancement. The downside of the
gadolinium enhancement is the potential inability to sup-
press interfering venous signals.
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